Financhill
Buy
88

DAVE Quote, Financials, Valuation and Earnings

Last price:
$200.76
Seasonality move :
-12.22%
Day range:
$195.00 - $206.40
52-week range:
$28.31 - $220.34
Dividend yield:
0%
P/E ratio:
55.32x
P/S ratio:
7.46x
P/B ratio:
13.43x
Volume:
608K
Avg. volume:
501.8K
1-year change:
323.05%
Market cap:
$2.7B
Revenue:
$347.1M
EPS (TTM):
$3.63
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $121.8M $153M $204.8M $259.1M $347.1M
Revenue Growth (YoY) 59.78% 25.63% 33.87% 26.49% 33.96%
 
Cost of Revenues $21.6M $23.5M $31.9M $28.9M $30.4M
Gross Profit $100.2M $129.6M $172.9M $230.2M $316.7M
Gross Profit Margin 82.23% 84.67% 84.4% 88.84% 91.25%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $60.2M $101M $172.5M $143.3M $151.9M
Other Inc / (Exp) -$4.5M $29.5M $16.3M $282K $30.7M
Operating Expenses $101.5M $176.4M $307.3M $272.4M $282.1M
Operating Income -$1.4M -$46.9M -$134.4M -$42.2M $34.6M
 
Net Interest Expenses $964K $2.5M $10.8M $6.5M $5M
EBT. Incl. Unusual Items -$6.8M -$19.9M -$129M -$48.4M $60.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $145K $97K -$67K $120K $2.5M
Net Income to Company -$7M -$20M -$128.9M -$48.5M $57.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7M -$20M -$128.9M -$48.5M $57.9M
 
Basic EPS (Cont. Ops) -$0.60 -$1.72 -$11.12 -$4.07 $4.62
Diluted EPS (Cont. Ops) -$0.60 -$1.72 -$11.12 -$4.07 $4.19
Weighted Average Basic Share $11.6M $11.6M $11.6M $11.9M $12.5M
Weighted Average Diluted Share $11.6M $11.6M $11.6M $11.9M $13.8M
 
EBITDA -$5.1M -$14.3M -$112.6M -$31.1M $76M
EBIT -$6.8M -$17.4M -$119.8M -$36.6M $68.3M
 
Revenue (Reported) $121.8M $153M $204.8M $259.1M $347.1M
Operating Income (Reported) -$1.4M -$46.9M -$134.4M -$42.2M $34.6M
Operating Income (Adjusted) -$6.8M -$17.4M -$119.8M -$36.6M $68.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $34.4M $42.6M $58.9M $73.6M $108M
Revenue Growth (YoY) -- 23.6% 38.49% 24.95% 46.65%
 
Cost of Revenues $5.2M $6.5M $7.1M $7.7M $7.1M
Gross Profit $29.2M $36M $51.8M $65.9M $100.9M
Gross Profit Margin 84.84% 84.62% 87.92% 89.51% 93.42%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.4M $30.1M $33.8M $33.6M $37.8M
Other Inc / (Exp) $14.6M -$7.6M $171K $32.8M $46K
Operating Expenses $39.5M $58.7M $64.3M $60.5M $65.7M
Operating Income -$10.3M -$22.7M -$12.5M $5.4M $35.1M
 
Net Interest Expenses $315K $2.5M $1.7M $722K $1.3M
EBT. Incl. Unusual Items $3.9M -$32.8M -$14M $37.4M $33.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$8K $22K $8K $3.2M $5.1M
Net Income to Company $4M -$32.8M -$14M $34.2M $28.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4M -$32.8M -$14M $34.2M $28.8M
 
Basic EPS (Cont. Ops) -- -$2.91 -$1.19 $2.80 $2.19
Diluted EPS (Cont. Ops) -- -$2.91 -$1.19 $2.60 $1.97
Weighted Average Basic Share $11.6M $11.3M $11.8M $12.2M $13.1M
Weighted Average Diluted Share $11.6M $11.3M $11.8M $13.2M $14.6M
 
EBITDA $7M -$30.1M -$9.9M $41.4M $37.2M
EBIT $4.2M -$31.2M -$11.1M $39.7M $35.6M
 
Revenue (Reported) $34.4M $42.6M $58.9M $73.6M $108M
Operating Income (Reported) -$10.3M -$22.7M -$12.5M $5.4M $35.1M
Operating Income (Adjusted) $4.2M -$31.2M -$11.1M $39.7M $35.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- $161.1M $221.2M $273.8M $381.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $24.8M $32.5M $29.5M $29.8M
Gross Profit -- $136.4M $188.7M $244.3M $351.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $107.7M $176.2M $143.1M $156.1M
Other Inc / (Exp) $11.1M $7.3M $24M $32.9M -$2M
Operating Expenses -- $195.6M $312.9M $268.6M $287.3M
Operating Income -- -$59.2M -$124.2M -$24.3M $64.4M
 
Net Interest Expenses $310K $4.7M $10M $5.5M $5.6M
EBT. Incl. Unusual Items -- -$56.6M -$110.2M $3.1M $56.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $127K -$81K $3.3M $4.3M
Net Income to Company -- -$56.7M -$110.1M -$249K $52.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$56.7M -$110.1M -$249K $52.4M
 
Basic EPS (Cont. Ops) -- -$4.97 -$9.41 -$0.08 $4.05
Diluted EPS (Cont. Ops) -- -$4.97 -$9.41 -$0.28 $3.63
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -$49.9M -$92.5M $20.2M $71.8M
EBIT -- -$52.8M -$99.7M $14.2M $64.3M
 
Revenue (Reported) -- $161.1M $221.2M $273.8M $381.4M
Operating Income (Reported) -- -$59.2M -$124.2M -$24.3M $64.4M
Operating Income (Adjusted) -- -$52.8M -$99.7M $14.2M $64.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $34.4M $42.6M $58.9M $73.6M $108M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.2M $6.5M $7.1M $7.7M $7.1M
Gross Profit $29.2M $36M $51.8M $65.9M $100.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.4M $30.1M $33.8M $33.6M $37.8M
Other Inc / (Exp) $14.6M -$7.6M $171K $32.8M $46K
Operating Expenses $39.5M $58.7M $64.3M $60.5M $65.7M
Operating Income -$10.3M -$22.7M -$12.5M $5.4M $35.1M
 
Net Interest Expenses $315K $2.5M $1.7M $722K $1.3M
EBT. Incl. Unusual Items $3.9M -$32.8M -$14M $37.4M $33.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$8K $22K $8K $3.2M $5.1M
Net Income to Company $4M -$32.8M -$14M $34.2M $28.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4M -$32.8M -$14M $34.2M $28.8M
 
Basic EPS (Cont. Ops) -- -$2.91 -$1.19 $2.80 $2.19
Diluted EPS (Cont. Ops) -- -$2.91 -$1.19 $2.60 $1.97
Weighted Average Basic Share $11.6M $11.3M $11.8M $12.2M $13.1M
Weighted Average Diluted Share $11.6M $11.3M $11.8M $13.2M $14.6M
 
EBITDA $7M -$30.1M -$9.9M $41.4M $37.2M
EBIT $4.2M -$31.2M -$11.1M $39.7M $35.6M
 
Revenue (Reported) $34.4M $42.6M $58.9M $73.6M $108M
Operating Income (Reported) -$10.3M -$22.7M -$12.5M $5.4M $35.1M
Operating Income (Adjusted) $4.2M -$31.2M -$11.1M $39.7M $35.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.8M $32M $22.9M $41.8M $49.7M
Short Term Investments $17.7M $8.2M $169.1M $114.2M $40.6M
Accounts Receivable, Net $38.7M $49M $104.2M $112.8M $175.9M
Inventory -- -- -- -- --
Prepaid Expenses $4M $1.4M $831K $148K --
Other Current Assets $4.1M $4.4M $11.6M $8M $16.1M
Total Current Assets $69.4M $100.2M $308.6M $276.9M $282.3M
 
Property Plant And Equipment $1.9M $3.4M $1.8M $1.9M $1.2M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $4.5M $7.8M $10.2M $13.2M $13.6M
Other Long-Term Assets $197K $363K $925K $1.7M $2M
Total Assets $76.4M $147.2M $321.5M $294M $299.3M
 
Accounts Payable $8.5M $13M $11.4M $5.5M $6.8M
Accrued Expenses $6.7M $14M $17.5M $10.9M $16.1M
Current Portion Of Long-Term Debt -- $695K -- -- --
Current Portion Of Capital Lease Obligations $400K $1.9M $273K $298K $350K
Other Current Liabilities $2.9M $1.2M $1.2M $715K $982K
Total Current Liabilities $24.2M $68.6M $36.4M $25.6M $35.1M
 
Long-Term Debt $708K $35M $177.3M $180.5M $75M
Capital Leases -- -- -- -- --
Total Liabilities $26.6M $108.4M $214.9M $207M $116.2M
 
Common Stock $72.2M $1K $1K $1K $1K
Other Common Equity Adj -- -- -$1.7M $649K $221K
Common Equity -$22.3M $38.7M $106.6M $87.1M $183.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $49.8M $38.7M $106.6M $87.1M $183.1M
 
Total Liabilities and Equity $76.4M $147.2M $321.5M $294M $299.3M
Cash and Short Terms $22.5M $40.2M $192M $155.9M $90.3M
Total Debt $4.6M $70.7M $177.3M $180.5M $75M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents -- $23.6M $51.8M $55.5M $47M
Short Term Investments -- $278.3M $143.3M $44.4M $41.1M
Accounts Receivable, Net -- $61.8M $80.2M $104.9M $194.7M
Inventory -- -- -- -- --
Prepaid Expenses -- $1.4M $824K -- --
Other Current Assets -- $10M $15.7M $13.5M $16M
Total Current Assets -- $375M $291.6M $218.3M $298.8M
 
Property Plant And Equipment -- $3.1M $1.9M $1.7M $1.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- $9.1M $11M $13.3M $13.7M
Other Long-Term Assets -- $447K $788K $2M $2M
Total Assets -- $387.8M $305.4M $235.6M $315.7M
 
Accounts Payable -- $13.6M $4.6M $9M $6.3M
Accrued Expenses -- $11.8M $13.3M $7.5M $13.9M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $1.7M $265K $310K $280K
Other Current Liabilities -- $8.3M $4.2M $1M $926K
Total Current Liabilities -- $58.8M $26.3M $29.2M $34.8M
 
Long-Term Debt -- $134.9M $178.1M $75M $75M
Capital Leases -- -- -- -- --
Total Liabilities -- $213.3M $205.4M $108.3M $116.2M
 
Common Stock -- $37K $1K $1K $1K
Other Common Equity Adj -- -- -$892K $3K $229K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $174.4M $100.1M $127.3M $199.5M
 
Total Liabilities and Equity -- $387.8M $305.4M $235.6M $315.7M
Cash and Short Terms -- $301.8M $195M $99.9M $88.1M
Total Debt -- $154.9M $178.1M $75M $75M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$7M -$20M -$128.9M -$48.5M $57.9M
Depreciation & Amoritzation $1.7M $3.1M $7.1M $5.5M $7.7M
Stock-Based Compensation $1.5M $7.4M $40.6M $26.7M $37.3M
Change in Accounts Receivable -- -- -- -$4.1M -$6.2M
Change in Inventories -- -- -- -- --
Cash From Operations -$9.1M -$541K -$44.9M $33.8M $125.1M
 
Capital Expenditures $4.2M $6.5M $9.3M $8.6M $7.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing $3.4M -$37.2M -$285.6M -$14.4M -$45.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3.9M $70M $140M -- --
Long-Term Debt Repaid -- -$3.9M -$20M -- -$71M
Repurchase of Common Stock -- -- -$536K -$12K --
Other Financing Activities -- -$2.8M $6.7M -- -$1.3M
Cash From Financing $4.2M $65M $321.8M $22K -$71M
 
Beginning Cash (CF) $6.6M $5.1M $32.4M $23.7M $43.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.5M $27.3M -$8.7M $19.4M $8.3M
Ending Cash (CF) $5.1M $32.4M $23.7M $43.1M $51.4M
 
Levered Free Cash Flow -$13.4M -$7M -$54.2M $25.2M $117.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $4M -$32.8M -$14M $34.2M $28.8M
Depreciation & Amoritzation $2.8M $1.2M $1.2M $1.7M $1.5M
Stock-Based Compensation $1.7M $3.2M $6.8M $6.1M $7.5M
Change in Accounts Receivable -- -- -- -$454K -$3.3M
Change in Inventories -- -- -- -- --
Cash From Operations -$1.7M -$12.5M -$6.9M $18.3M $45.2M
 
Capital Expenditures $3.3M $2.5M $2.2M $1.6M $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing $4.9M -$297.6M $35.8M $66.1M -$28.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $19M $100M -- -- --
Long-Term Debt Repaid -$3.9M -- -- -$71M --
Repurchase of Common Stock -- -$1.6M -$13K -- -$6.9M
Other Financing Activities -$120K $6.7M -- -- -$13.3M
Cash From Financing $15.6M $301.7M -$12K -$70.5M -$19.9M
 
Beginning Cash (CF) $5.1M $32.4M $23.7M $43.1M $51.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $18.8M -$8.4M $28.9M $14M -$2.7M
Ending Cash (CF) $23.9M $24M $52.5M $57.1M $48.7M
 
Levered Free Cash Flow -$5M -$15M -$9.1M $16.7M $43.8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -$56.7M -$110.1M -$249K $52.4M
Depreciation & Amoritzation -- $1.4M $7.2M $6.1M $7.5M
Stock-Based Compensation $1.7M $8.9M $44.2M $26M $38.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -$11.4M -$39.3M $59M $152M
 
Capital Expenditures $3.3M $5.7M $9M $8M $7.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$339.7M $47.8M $15.9M -$140M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $151M -- -- --
Long-Term Debt Repaid -- -- -- -$71M --
Repurchase of Common Stock -- -$1.6M $1M $1K -$6.9M
Other Financing Activities -- $4.1M -- -- -$14.6M
Cash From Financing -- $351.2M $20M -$70.4M -$20.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $149K $28.5M $4.5M -$8.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -$17M -$48.3M $51.1M $144.7M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $4M -$32.8M -$14M $34.2M $28.8M
Depreciation & Amoritzation $2.8M $1.2M $1.2M $1.7M $1.5M
Stock-Based Compensation $1.7M $3.2M $6.8M $6.1M $7.5M
Change in Accounts Receivable -- -- -- -$454K -$3.3M
Change in Inventories -- -- -- -- --
Cash From Operations -$1.7M -$12.5M -$6.9M $18.3M $45.2M
 
Capital Expenditures $3.3M $2.5M $2.2M $1.6M $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing $4.9M -$297.6M $35.8M $66.1M -$28.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $19M $100M -- -- --
Long-Term Debt Repaid -$3.9M -- -- -$71M --
Repurchase of Common Stock -- -$1.6M -$13K -- -$6.9M
Other Financing Activities -$120K $6.7M -- -- -$13.3M
Cash From Financing $15.6M $301.7M -$12K -$70.5M -$19.9M
 
Beginning Cash (CF) $5.1M $32.4M $23.7M $43.1M $51.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $18.8M -$8.4M $28.9M $14M -$2.7M
Ending Cash (CF) $23.9M $24M $52.5M $57.1M $48.7M
 
Levered Free Cash Flow -$5M -$15M -$9.1M $16.7M $43.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock